Nephron Pharmaceuticals is a leader in sterile pharmaceutical manufacturing, specializing in preservative-free respiratory inhalation therapies. Their comprehensive portfolio of sterile inhalation solutions serves a wide range of healthcare settings, from hospitals and long-term care facilities to retail pharmacies and mail-order pharmacies. Nephron’s dedication to sterility, safety, and accessibility ensures that every product meets the stringent quality standards required for respiratory therapy delivery.
Manufactured entirely in the United States, Nephron’s respiratory medications are produced in state-of-the-art 503B outsourcing facilities, where automation and aseptic processing technologies minimize contamination risks and ensure consistent product integrity. Each dose is individually wrapped and barcoded, facilitating bedside scanning and medication verification, which is a key component in preventing administration errors and maintaining compliance within pharmacy workflows.
Nephron’s respiratory portfolio reflects an understanding of both clinical and operational pharmacy needs. Through a commitment to preservative-free formulations, the company prioritizes patient safety and medication tolerability, especially for vulnerable populations such as pediatric, geriatric, and chronic respiratory patients.
Key Highlights of Nephron’s Respiratory Therapy Products:
- Sterile, Preservative-Free Formulations: Designed for sensitive respiratory patients and compliant with FDA manufacturing standards.
- Individually Wrapped & Barcoded Units: Simplifies tracking, verification, and integration with automated dispensing systems.
- Made in the USA: Ensures full supply chain transparency and reliability for critical respiratory medications.
- Wide Range of Applications: Supports treatments for asthma, COPD, and other respiratory conditions across hospital and outpatient settings.
